Ron Bentsur - 08 Aug 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
08 Aug 2023
Net transactions value
+$4,418
Form type
4
Filing time
11 Aug 2023, 18:07:57 UTC
Previous filing
24 Jul 2023
Next filing
16 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1,780 +120 +0% $14.83 3,232,014 08 Aug 2023 Direct F1
transaction NVCT Common Stock Purchase $2,639 +180 +0.01% $14.66 3,232,194 11 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 426,759 shares of restricted stock.